A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer
Advanced Materials · 2024
DOI: 10.1002/adma.202314309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Meng Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immunotherapy, Tumor Microenvironment, B7-H1 Antigen. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, the talent cultivation project Funds for the Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province.
Abstract (Originalsprache)
Triple negative breast cancer (TNBCs), known as an immunologically cold tumor, is difficult to completely eliminate with existing monotherapies, let alone metastasis and recurrence. It is urgent to design a rational combination of multiple therapies to programmatically reconstitute tumor microenvironment (TME) and reverse the immune “cold” into “hot” inflammatory tumors to improve the therapeutic effect. Hence, in this work, a multifunctional nanosystem (FeSH NPs) that integrates metal‐polyphenol coordination complex as a photothermal agent and polyphenol, salvianolic acid B (SAB) as immunomodulator is designed and fabricated for synergistic photothermal‐immunotherapy of TNBCs combined with anti‐PD‐L1 antibody. Guided by photothermal/photoacoustic dual‐mode imaging, photothermal therapy (PTT) caused by FeSH NPs induces immunogenic cell death (ICD) under 808 nm laser irradiation. Subsequently, the loaded SAB is released with the addition of deferoxamine mesylate (DFO) to remodel TME, specifically TGF‐β inhibition and PD‐L1 upregulation, and eliminate the primary tumors. The combination of PTT and TME reprogramming by FeSH NPs further synergizes with anti‐PD‐L1 antibody to eradicate recurrence and inhibit metastasis of TNBCs concurrently. Given the biosafety of FeSH NPs throughout the lifecycle, this work provides a protocol with high clinical translational promise for comprehensive programmed therapeutics of immunologically cold tumors TNBCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China.
- State Key Laboratory of Physical Chemistry of Solid Surfaces, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China.
- School of Materials Science and Engineering, Xiamen University of Technology, Xiamen, 361024, China.
- Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province (IKKEM), Xiamen, 361005, China.
ORCID-Profile: Huayu Tian
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- the talent cultivation project Funds for the Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province
- the Research Foundation for Advanced Talents of Xiamen University of Technology
Zitieren
APA
Meng, M., Wu, J., Feng, Y., Lin, L., Chen, J., Pang, X., Li, Y., Hao, K., Tian, H., & Chen, X. (2024). A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer. Advanced Materials. https://doi.org/10.1002/adma.202314309
Vancouver
Meng M, Wu J, Feng Y, Lin L, Chen J, Pang X, et al. A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer. Advanced Materials. 2024. doi:10.1002/adma.202314309
BibTeX
@article{Meng2024,
author = {Meng, Meng and Wu, Jiayan and Feng, Yuanji and Lin, Lin and Chen, Jie and Pang, Xuan and Li, Yanhui and Hao, Kai and Tian, Huayu and Chen, Xuesi},
title = {A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202314309}
}
EUVIMED